Market Research Logo

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2017-2021

Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2017-2021

About Human Immunodeficiency Virus (HIV) Rapid Test Kits

HIV rapid test kits help in determining the presence of antibodies for HIV in body fluids. The test kits include simple, single-use, disposable devices that can provide results within limited time. These devices are designed for using unprocessed specimens such as saliva and blood to detect antibodies. Based on the test, the HIV rapid test kits are of two types, namely, rapid immunoassay test and rapid molecular diagnostic test.

Technavio’s analysts forecast the global human immunodeficiency virus (HIV) rapid test kits market to grow at a CAGR of 7.23% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global human immunodeficiency virus (HIV) rapid test kits market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • F. Hoffmann-La Roche
  • Alere
Other prominent vendors
  • Abbott
  • AccuBioTech
  • Access Bio
  • Ameritek
  • ALL.DIAG
  • Atomo Diagnostics
  • Autobio Diagnostics
  • Beckman Coulter
  • BD Biosciences
  • Bionor
  • Bio Focus
  • Bio-Rad Laboratories
  • bioMérieux
  • Bundi International Diagnostics
  • Calypte Biomedical
  • CS Innovation
  • Cortez Diagnostics
  • EY Laboratories
  • Hangzhou Biotest Biotech
  • Hema Diagnostics System
  • Hologic
  • JAL Innovation
  • LifeSign
  • Maccura Biotechnology
  • MedMira
  • Medinostics
  • MPI Diagnostics
  • Nectar Lifesciences
  • NTBIO Diagnostics
  • OraSure Technologies
  • PointCare
  • Premier Medical
  • Qiagen
  • Savyon Diagnostics
  • Shanghai Kehua Bioengineering
  • Span Diagnostics
  • Sysmex
  • Trinity Biotech
  • Turklab Tibbi Malzemeler San. Tic.
  • ViennaLab Diagnostics
  • Voxtur Bio
  • Wama Diagnostica
Market driver
  • Some favorable reimbursements in developed countries
  • For a full, detailed list, view our report
Market challenge
  • High accuracy of ELISA over HIV rapid test kits
  • For a full, detailed list, view our report
Market trend
  • Growing preference for self-testing
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?


Press Release

Technavio Announces the Publication of its Research Report – Global Human Immunodeficiency Virus (HIV) Rapid Test Kits Market 2017-2021

Technavio recognizes the following companies as the key players in the global human immunodeficiency virus (HIV) rapid test kits market: F. Hoffmann-La Roche, and Alere.

Other Prominent Vendors in the market are: Abbott, AccuBioTech, Access Bio, Ameritek, ALL.DIAG, Atomo Diagnostics, Autobio Diagnostics, Beckman Coulter, BD Biosciences, Bionor, Bio Focus, Bio-Rad Laboratories, bioMérieux, Bundi International Diagnostics, Calypte Biomedical, CS Innovation, Cortez Diagnostics, EY Laboratories, Hangzhou Biotest Biotech, Hema Diagnostics System, Hologic, JAL Innovation, LifeSign , Maccura Biotechnology, MedMira, Medinostics, MPI Diagnostics, Nectar Lifesciences, NTBIO Diagnostics, OraSure Technologies, PointCare, Premier Medical, Qiagen, Savyon Diagnostics, Shanghai Kehua Bioengineering, Span Diagnostics, Sysmex, Trinity Biotech, Turklab Tibbi Malzemeler San. Tic., ViennaLab Diagnostics, Voxtur Bio, and Wama Diagnostica.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is growing preference for self-testing. HIV self-testing in home setting only marks the presence of HIV-1/2 antibodies or the HIV-1 p24 antigen, it does not provide diagnosis. The self-testing kit has an inbuilt control line, which makes the performance of the test accurate and reliable. The increasing preference for the self-testing procedure will drive the adoption of the HIV rapid test kits among people.”

According to the report, one driver in the market is some favorable reimbursements in developed countries. The favorable reimbursement scenario is an important contributor to the market growth. The US, Australia, and some countries in the EU are offering limited reimbursement coverage for laboratory testing. For instance, in the US, the Florida Individual Health Insurance Plans Preventive Services Coverage for HIV Testing is offered by both public and private payors, namely Aetna, AvMed, CIGNA, UnitedHealthcare, Humana, and Medicaid, for its citizens. Reimbursements offered by insurance companies to the end-users help in increasing the market adoption and expanding business geographically.

Further, the report states that one challenge in the market is high accuracy of ELISA over HIV rapid test kits. One of the market constraints for the HIV rapid test kits are the false results, which proves the inefficiency of these kits. This has largely impacted the adoption of HIV rapid test kits negatively. According to a NCBI study conducted by the Department of Microbiology, Maulana Azad Medical College, India, revealed that in 2014, the detection of HIV status by using HIV rapid test kits were poor than ELISA. The study was conducted with the help of SD Bioline HIV-1/2 3.0 and Microlisa-HIV, where 787 serum samples were tested for anti-HIV antibodies.

Companies Mentioned

F. Hoffmann-La Roche, and Alere, Abbott, AccuBioTech, Access Bio, Ameritek, ALL.DIAG, Atomo Diagnostics, Autobio Diagnostics, Beckman Coulter, BD Biosciences, Bionor, Bio Focus, Bio-Rad Laboratories, bioMérieux, Bundi International Diagnostics, Calypte Biomedical, CS Innovation, Cortez Diagnostics, EY Laboratories, Hangzhou Biotest Biotech, Hema Diagnostics System, Hologic, JAL Innovation, LifeSign , Maccura Biotechnology, MedMira, Medinostics, MPI Diagnostics, Nectar Lifesciences, NTBIO Diagnostics, OraSure Technologies, PointCare, Premier Medical, Qiagen, Savyon Diagnostics, Shanghai Kehua Bioengineering, Span Diagnostics, Sysmex, Trinity Biotech, Turklab Tibbi Malzemeler San. Tic., ViennaLab Diagnostics, Voxtur Bio, and Wama Diagnostica.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
      • Table Benefits associated with HIV rapid test kits
  • Market landscape
    • Market overview
      • Table Market overview: Global HIV rapid test kits market 2016
      • Table Market share of global HIV rapid test kits market by technology 2016
    • Market size and forecast
      • Table Global HIV rapid test kits market 2016-2021 ($ millions)
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by end-user
    • Market overview
      • Table Segmentation of global HIV rapid test kits market by end-user 2016
      • Table Strategical analysis of global HIV rapid test kits market by end-users 2016
    • Hospitals and clinics
    • Diagnostic centers
      • Table Buying criteria analysis: Global HIV rapid test kits market 2016
  • Geographical segmentation
    • Market overview
      • Table Global HIV rapid test kits market by geography in 2016 and 2021 ($ millions)
    • HIV rapid test kits market in Americas
      • Table Market overview: HIV rapid test kits market in Americas 2016-2021
      • Table HIV rapid test kits market in Americas 2016-2021 ($ millions)
    • HIV rapid test kits market in EMEA
      • Table Market overview: HIV rapid test kits market in EMEA 2016-2021
      • Table HIV rapid test kits market in EMEA 2016-2021 ($ millions)
    • HIV rapid test kits market in APAC
      • Table Market overview: HIV rapid test kits market in APAC 2016-2021
      • Table HIV rapid test kits market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Rate of AIDS prevalence globally 2015
      • Table List of approvals by regulatory bodies for HIV rapid test kits
      • Table Healthcare common procedure coding systems (HCPCS) for billing
    • Market challenges
      • Table Product recalls of HIV rapid test kits
  • Market trends
    • Growing preference for self-testing
    • Increase in testing programs to prove the accuracy of rapid test kits
    • Growth in campaigns to educate people about HIV
  • Vendor landscape
    • Competitive landscape
      • Table Competitive structure analysis of global HIV rapid test kits market 2016
      • Table Penetration of various global HIV rapid test kits market providers 2016
      • Table Strategic success factors of companies in global HIV rapid test kits market 2016
  • Key vendor analysis
    • Alere
      • Table Alere: Key highlights
      • Table Alere: Strength assessment
      • Table Alere: Strategy assessment
      • Table Alere: Opportunity assessment
    • F. Hoffmann-La Roche
      • Table F. Hoffmann-La Roche: Key highlights
      • Table F. Hoffmann-La Roche: Strength assessment
      • Table F. Hoffmann-La Roche: Strategy assessment
      • Table F. Hoffmann-La Roche: Opportunity assessment
    • Key companies to watch
      • Table bioLytical Laboratories: Company assessment
      • Table Chembio Diagnostic Systems: Company assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report